Washington, Dec 16 (ANI): Higher levels of a protein hormone, called leptin, which is produced by fat cells and involved in the regulation of appetite, could lower the risk of Alzheimer’s disease and dementia, according to a study.

In earlier studies, it was shown that overweight and obesity in mid-life are associated with poorer cognitive function in the general population and an increased risk of dementia.

There has been evidence that leptin exerts additional functions on the brain outside the hypothalamus (a region of the brain that controls body temperature, hunger, and thirst).

Dr. Wolfgang Lieb, of the Framingham Heart Study, Framingham, Mass., and colleagues examined the relationship between measurements of plasma leptin concentrations and incidence of dementia and Alzheimer disease (AD).

For the study, plasma leptin concentrations were measured in 785 persons without dementia (average age, 79 years; 62 percent female), who were in the original Framingham study group at the 22nd examination cycle (1990-1994).

A sub sample of 198 dementia-free survivors underwent volumetric brain magnetic resonance imaging (MRI) between 1999 and 2005, approximately 7.7 years after leptin was measured.

Two measures of brain aging were assessed- total cerebral brain volume and temporal horn (a region of the brain) volume, both of which are markers of early AD pathology and subsequent dementia risk.

The researchers conducted follow-up for new cases of dementia and AD until Dec. 2007. During a median (midpoint) follow-up of 8.3 years, 111 participants developed dementia; 89 of them were diagnosed with AD.

The researchers found that higher leptin levels were associated with a lower incidence of all-cause dementia and AD.

The incidence of dementia decreased gradually across increasing levels of leptin.

Higher leptin levels were also associated with higher total cerebral brain volume. Lower temporal horn volume was not significantly related to leptin levels.

“These findings are consistent with recent experimental data indicating that leptin improves memory function in animals through direct effects on the hippocampus and strengthens the evidence that leptin is a hormone with a broad set of actions in the central nervous system. Due to the exploratory character of the present analyses, we did not adjust for multiple comparisons and acknowledge that our findings require confirmation in independent samples,” wrote the authors.

“If our findings are confirmed by others, leptin levels in older adults may serve as one of several possible biomarkers for healthy brain aging and, more importantly, may open new pathways for possible preventive and therapeutic intervention. Further exploration of the molecular and cellular basis for the observed association may expand our understanding of the pathophysiology underlying brain aging and the development of AD,” they added.

The study has been published in the latest issue of JAMA. (ANI)